Literature DB >> 103122

Monoamine oxidase activity in different density gradient fractions of human platelets.

D L Murphy, J L Costa, B Shafer, L Corash.   

Abstract

Monoamine oxidase (MAO) activity measured in human platelets is reportedly altered by such drugs as epinephrine, lithium carbonate, and imipramine, and also reduced in a number of clinical disorders. To evaluate whether MAO activity might differ in platelet subpopulations, density gradient centrifugation with arabino-galactan was used to prepare four platelet fractions that differed in weight and volume. MAO activity in the lightest and smallest platelet subpopulation was approximately one-half that in the heaviest and largest subpopulation. Because platelet weight and size are thought to be related to platelet age, it is possible that some drug effects on platelet MAO activity might represent changes in platelet turnover. Factors other than platelet turnover rates may contribute to individual differences in platelet MAO activity, however, since one group of individuals with markedly reduced platelet MAO activity exhibited no shift in the proportion of lighter versus heavier platelets nor in the relative amount of MAO activity in each density gradient subfraction.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 103122     DOI: 10.1007/bf00427757

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  22 in total

1.  Substrate- and inhibitor-related characteristics of human platelet monoamine oxidase.

Authors:  C H Donnelly; D L Murphy
Journal:  Biochem Pharmacol       Date:  1977-05-01       Impact factor: 5.858

Review 2.  Neuronal monoamine oxidase: specific enzyme types and their rates of formation.

Authors:  N H Neff; C Goridis
Journal:  Adv Biochem Psychopharmacol       Date:  1972

3.  Monamine oxidase in schizophrenia and other behavioral disorders.

Authors:  D L Murphy; R Belmaker; R J Wyatt
Journal:  J Psychiatr Res       Date:  1974       Impact factor: 4.791

4.  The exchangeable splenic platelet pool studied with epinephrine infusion in idiopathic thrombocytopenic purpura and in patients with splenomegaly.

Authors:  I Branehög; A Weinfeld; B Roos
Journal:  Br J Haematol       Date:  1973-08       Impact factor: 6.998

5.  The effect of adrenaline on human platelet MAO activity.

Authors:  V Gentil; M H Greenwood; M H Lader
Journal:  Psychopharmacologia       Date:  1975-10-31

6.  Heterogeneity of human whole blood platelet subpopulations. I. Relationship between buoyant density, cell volume, and ultrastructure.

Authors:  L Corash; H Tan; H R Gralnick
Journal:  Blood       Date:  1977-01       Impact factor: 22.113

7.  Increased human platelet monoamine oxidase activity during lithium carbonate therapy.

Authors:  J Bockar; R Roth; G Heninger
Journal:  Life Sci       Date:  1974-12-15       Impact factor: 5.037

8.  Human platelet monoamine oxidase activity in iron-deficiency anaemia.

Authors:  M B Youdim; H F Woods; B Mitchell; D G Grahame-Smith; S Callender
Journal:  Clin Sci Mol Med       Date:  1975-04

9.  Monoamine oxidase in chronic schizophrenia: Studies of hormonal and other factors affecting enzyme activity.

Authors:  D L Murphy; R Belmaker; W T Carpenter; R J Wyatt
Journal:  Br J Psychiatry       Date:  1977-02       Impact factor: 9.319

10.  The biochemical high-risk paradigm: behavioral and familial correlates of low platelet monoamine oxidase activity.

Authors:  M S Buchsbaum; R D Coursey; D L Murphy
Journal:  Science       Date:  1976-10-15       Impact factor: 47.728

View more
  8 in total

1.  Platelet monoamine oxidase activity in megaloblastic anaemia.

Authors:  V Glover; M Sandler; A Hughes; A V Hoffbrand
Journal:  J Clin Pathol       Date:  1980-10       Impact factor: 3.411

2.  Monoamine oxidase activity and enzyme kinetics in three subpopulations of density-fractionated platelets in chronic paranoid schizophrenics.

Authors:  J J Mann; R D Kaplan; A Georgotas; E Friedman; M Branchey; S Gershon
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

3.  Hemostatic function, survival, and membrane glycoprotein changes in young versus old rabbit platelets.

Authors:  M A Blajchman; A F Senyi; J Hirsh; E Genton; J N George
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

4.  Platelet monoamine oxidase activity in epilepsy.

Authors:  Z L Kruk; A Moffett; D F Scott
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-01       Impact factor: 10.154

Review 5.  Clinical neurochemistry of autism and associated disorders.

Authors:  J G Young; M E Kavanagh; G M Anderson; B A Shaywitz; D J Cohen
Journal:  J Autism Dev Disord       Date:  1982-06

6.  Vitamin B12-induced reduction of platelet monoamine oxidase activity in patients with dementia and pernicious anaemia.

Authors:  B Regland; C G Gottfries; L Oreland
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

Review 7.  Human platelet monoamine oxidase activity in health and disease: a review.

Authors:  M Sandler; M A Reveley; V Glover
Journal:  J Clin Pathol       Date:  1981-03       Impact factor: 3.411

8.  Platelet size: no correlation with migraine or monoamine oxidase activity.

Authors:  R C Peatfield; M J Gawel; D L Guthrie; T C Pearson; V Glover; J Littlewood; M Sandler; F C Rose
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-09       Impact factor: 10.154

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.